PROTHENA CORPORATION PUBLIC LIMITED COMPANY Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2018-11-06: Form 10-Q; Exhibit 10.2.A; Description Sub-Sublease, dated as of July 18, 2018, between Prothena Biosciences Inc and Assembly Biosciences, Inc..
- 2018-11-06: Form 10-Q; Exhibit 10.2.B; Description Consent to Sub-Sublease, dated as of September 19, 2018, among Prothena Biosciences Inc, Assembly Biosciences. Inc., Amgen Inc. and HCP BTC, LLC.
- 2018-11-06: Form 10-Q; Exhibit 10.1; Description Termination and Release Agreement, dated July 20, 2018, between Prothena Biosciences Limited and Rentschler Biopharma SE.
- 2018-08-17: Form 10-Q/A; Exhibit 10.3; Description Master Collaboration Agreement, dated as of March 20, 2018, between Prothena Biosciences Limited and Celgene Switzerland LLC.
| Filed | Form | Exhibit | Description |
|---|
| 2018-11-06 | 10-Q | 10.2.A | Sub-Sublease, dated as of July 18, 2018, between Prothena Biosciences Inc and Assembly Biosciences, Inc. |
|---|
| 2018-11-06 | 10-Q | 10.2.B | Consent to Sub-Sublease, dated as of September 19, 2018, among Prothena Biosciences Inc, Assembly Biosciences. Inc., Amgen Inc. and HCP BTC, LLC |
|---|
| 2018-11-06 | 10-Q | 10.1 | Termination and Release Agreement, dated July 20, 2018, between Prothena Biosciences Limited and Rentschler Biopharma SE |
|---|
| 2018-08-17 | 10-Q/A | 10.3 | Master Collaboration Agreement, dated as of March 20, 2018, between Prothena Biosciences Limited and Celgene Switzerland LLC |
|---|
| 2018-08-17 | 10-Q/A | 10.2 | Exclusive License Agreement, dated as of July 25, 2016, between University Health Network and Prothena Biosciences Limited |
|---|
| 2018-08-17 | 10-Q/A | 10.1A | License Agreement, dated as of November 4, 2013, between The Regents of the University of California and Neotope Biosciences Limited |
|---|
| 2018-08-17 | 10-Q/A | 10.1B | License Agreement Amendment Number One, dated as of January 15, 2014, to License Agreement dated as of November 4, 2013, between The Regents of the University of California and Neotope Biosciences Limited |
|---|
| 2018-08-07 | 10-Q | 10.3 | Form of Option Award Agreement between Prothena Corporation plc and Registrant’s Named Executive Officers under the Prothena Corporation plc 2018 Long Term Incentive Plan (used beginning June 21, 2018) |
|---|
| 2018-08-07 | 10-Q | 10.2 | Form of Option Award Agreement between Prothena Corporation plc and Registrant’s Non-Employee Directors under the Prothena Corporation plc 2018 Long Term Incentive Plan (used beginning May 16, 2018) |
|---|
| 2018-08-07 | 10-Q | 10.1 | Separation Agreement, dated May 23, 2018, between Prothena Biosciences Inc and Tara Nickerson |
|---|
| 2018-05-18 | 8-K | 10.1 | Prothena Corporation plc 2018 Long Term Incentive Plan |
|---|
| 2018-05-09 | 10-Q | 10.4 | Share Subscription Agreement, dated as of March 20, 2018, between Celgene Switzerland LLC and Prothena Corporation plc |
|---|
| 2018-05-09 | 10-Q | 10.3 | Master Collaboration Agreement, dated as of March 20, 2018, between Prothena Biosciences Limited and Celgene Switzerland LLC |
|---|
| 2018-05-09 | 10-Q | 10.2 | Exclusive License Agreement, dated as of July 25, 2016, between University Health Network and Prothena Biosciences Limited |
|---|
| 2018-05-09 | 10-Q | 10.1.A | License Agreement, dated as of November 4, 2013, between The Regents of the University of California and Neotope Biosciences Limited |
|---|
| 2018-05-09 | 10-Q | 10.1.B | License Agreement Amendment Number One, dated as of January 15, 2014, to License Agreement dated as of November 4, 2013, between The Regents of the University of California and Neotope Biosciences Limited |
|---|